Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
PAVmed Inc. (NASDAQ: PAVM)
PAVM Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
15.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
PAVM Stock Analysis
PAVM
PE Ratio:
PAVM
PEG Ratio:
Not Available
PAVM
Forward EPS Growth (12 month):
0.00%
PAVM
PS Ratio:
37.9
PAVM
PSG Ratio:
1.1
PAVM
Forward Revenue Growth (12 month):
33.20%
PAVM Articles
No data was found